JP2011515494A - テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法 - Google Patents

テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法 Download PDF

Info

Publication number
JP2011515494A
JP2011515494A JP2011502063A JP2011502063A JP2011515494A JP 2011515494 A JP2011515494 A JP 2011515494A JP 2011502063 A JP2011502063 A JP 2011502063A JP 2011502063 A JP2011502063 A JP 2011502063A JP 2011515494 A JP2011515494 A JP 2011515494A
Authority
JP
Japan
Prior art keywords
eyelid
blepharitis
disease
eye
margin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011502063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011515494A5 (enExample
Inventor
エリック ドネンフェルド，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2011515494A publication Critical patent/JP2011515494A/ja
Publication of JP2011515494A5 publication Critical patent/JP2011515494A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011502063A 2008-03-26 2009-03-26 テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法 Pending JP2011515494A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7085008P 2008-03-26 2008-03-26
US61/070,850 2008-03-26
PCT/US2009/038428 WO2009120881A1 (en) 2008-03-26 2009-03-26 Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics

Publications (2)

Publication Number Publication Date
JP2011515494A true JP2011515494A (ja) 2011-05-19
JP2011515494A5 JP2011515494A5 (enExample) 2013-04-18

Family

ID=40750879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011502063A Pending JP2011515494A (ja) 2008-03-26 2009-03-26 テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法

Country Status (6)

Country Link
US (1) US20110059925A1 (enExample)
EP (1) EP2285346A1 (enExample)
JP (1) JP2011515494A (enExample)
AU (1) AU2009228205A1 (enExample)
CA (1) CA2719453A1 (enExample)
WO (1) WO2009120881A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015504181A (ja) * 2012-01-06 2015-02-05 インサイト・ビジョン・インコーポレイテッド コンタクトレンズの使用を延長させるための方法およびキット
WO2016159351A1 (ja) * 2015-04-03 2016-10-06 参天製薬株式会社 涙腺ドラッグデリバリーシステム
JP2019532931A (ja) * 2016-09-22 2019-11-14 ノバリック ゲーエムベーハー 眼瞼炎の治療に使用するための医薬組成物

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090043365A1 (en) * 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US8950405B2 (en) 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US7981146B2 (en) 2006-05-15 2011-07-19 Tearscience Inc. Inner eyelid treatment for treating meibomian gland dysfunction
US7981095B2 (en) * 2005-07-18 2011-07-19 Tearscience, Inc. Methods for treating meibomian gland dysfunction employing fluid jet
WO2013003594A2 (en) 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US20070060988A1 (en) 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US20080114423A1 (en) 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
US20070016256A1 (en) * 2005-07-18 2007-01-18 Korb Donald R Method and apparatus for treating gland dysfunction
US8128673B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8007524B2 (en) 2006-05-15 2011-08-30 Tearscience, Inc. Heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8128674B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8137390B2 (en) 2006-05-15 2012-03-20 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
US7976573B2 (en) 2006-05-15 2011-07-12 Tearscience, Inc. Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US7981147B2 (en) 2006-05-15 2011-07-19 Tearscience, Inc. Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US10842670B2 (en) 2012-08-22 2020-11-24 Johnson & Johnson Vision Care, Inc. Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
US9763827B2 (en) 2013-04-30 2017-09-19 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
ES2942724T3 (es) 2013-04-30 2023-06-06 Alcon Inc Sistemas para el tratamiento de enfermedades del ojo
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
EP3199163A4 (en) * 2014-09-23 2018-06-20 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
KR20180090251A (ko) * 2015-09-28 2018-08-10 아주라 오프탈믹스 엘티디 마이봄샘 지질 분비를 증가시키기 위한 티올 및 이황화물 함유 약제
EP3442519A4 (en) 2016-04-14 2019-12-04 Azura Opthalmics Ltd. SELDISULFID COMPOSITIONS FOR USE IN THE TREATMENT OF THE MEIBOM DRESSING DYSFUNCTION
US10974063B2 (en) 2016-06-30 2021-04-13 Alcon Inc. Light therapy for eyelash growth
US20180221407A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses
KR20250065422A (ko) 2017-12-15 2025-05-12 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
EP3741367A1 (en) * 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
CN115279458A (zh) 2020-01-10 2022-11-01 阿祖拉眼科有限公司 组合物和敏感性说明
CA3199736A1 (en) 2020-11-23 2022-05-27 Sight Sciences, Inc. Formulations and methods for treating conditions of the eye

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001089378A (ja) * 1999-08-09 2001-04-03 Sifi Soc Industria Farmaceutica It Spa 眼科用水性薬剤の製造方法
JP2002514602A (ja) * 1998-05-08 2002-05-21 ユニバーシティ オブ マイアミ マイボーム腺疾病の処置におけるテトラサイクリン類の使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US7069084B2 (en) * 2002-06-14 2006-06-27 Seefit Incorporated Method and apparatus for preventing and treating eyelid problems

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514602A (ja) * 1998-05-08 2002-05-21 ユニバーシティ オブ マイアミ マイボーム腺疾病の処置におけるテトラサイクリン類の使用
JP2001089378A (ja) * 1999-08-09 2001-04-03 Sifi Soc Industria Farmaceutica It Spa 眼科用水性薬剤の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013043437; あたらしい眼科，１９９７．Ｖｏｌ．１４，Ｎｏ．１１，ｐ１６１３-１６２１ *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015504181A (ja) * 2012-01-06 2015-02-05 インサイト・ビジョン・インコーポレイテッド コンタクトレンズの使用を延長させるための方法およびキット
WO2016159351A1 (ja) * 2015-04-03 2016-10-06 参天製薬株式会社 涙腺ドラッグデリバリーシステム
JP2019532931A (ja) * 2016-09-22 2019-11-14 ノバリック ゲーエムベーハー 眼瞼炎の治療に使用するための医薬組成物
JP7012075B2 (ja) 2016-09-22 2022-01-27 ノバリック ゲーエムベーハー 眼瞼炎の治療に使用するための医薬組成物

Also Published As

Publication number Publication date
US20110059925A1 (en) 2011-03-10
EP2285346A1 (en) 2011-02-23
AU2009228205A1 (en) 2009-10-01
CA2719453A1 (en) 2009-10-01
WO2009120881A1 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
JP2011515494A (ja) テトラサイクリンファミリー抗生物質を用いる、眼瞼縁および涙液膜機能の改善ならびに眼瞼縁疾患の処置のための方法
JP5878172B2 (ja) 炎症性眼疾患の治療／予防用化合物
CN102811610B (zh) 无刺激性眼科聚维酮碘组合物
EP2313103B1 (en) Method of treating blepharitis
JP6994061B2 (ja) ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
CN1964719B (zh) 依碳酸氯替泼诺用于制备治疗干眼症的药物的用途
CN104661663A (zh) 用于眼部疾病和病症的组合物和治疗
US20120027842A1 (en) Topical formulations of flap inhibitors for administration to an eye
JP2025004186A (ja) 眼表面疼痛を治療する方法
US20130281390A1 (en) Method for treating dry eye
ES2984281T3 (es) Composiciones que comprenden un antagonista de la aldosterona para su uso en el tratamiento de ojos secos
JP2022541013A (ja) 肝臓ｘ受容体アゴニストでマイボーム腺機能不全を治療するための方法
US20130274214A1 (en) Method for treating blepharitis
RU2459615C1 (ru) Глазные капли для лечения болезни сухого глаза
JP2025118614A (ja) 前部眼瞼炎および後部眼瞼炎の処置のための組成物および方法
WO2022187306A1 (en) Compositions and methods for treatment of blepharitis
RU2836815C1 (ru) Офтальмологические композиции для местного применения на ксантановой основе с сокращенным режимом дозирования
JP2024542280A (ja) アラニル－グルタミンおよびアラニル－グルタミンを含む眼科用組成物の新規な使用
US20230064711A1 (en) Compositions, kits and methods for enhancing therapeutic compliance
CN104902892A (zh) 泪液膜稳定性的改进
JP2021517139A (ja) 選択的ｓｙｋ阻害剤の使用方法および医薬組成物
Al-Saedi Formulation and in vitro evaluation of cyclosporine A inserts prepared using HPMC for treating dry eye disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130830

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131129

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140422